# A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

> **NCT07719348** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Servier** · enrollment: 64 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Chronic Myelomonocytic Leukemia
- Myelodysplastic Syndrome Acute Myeloid Leukemia

## Interventions

- **DRUG:** S241656
- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT07719348
- **Lead sponsor:** Servier
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2027-11-01
- **Final completion:** 2030-09-30
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07719348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07719348, "A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07719348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*